ArticleJournal of thoracic disease2026

Survival benefit of neoadjuvant therapies in patients with surgically resected non-small cell lung cancer with pathologic complete response.

Isheeta Madeka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.